Stay informed with the latest updates for the inheritable blood disorders community. Industry NBDF and WFH statement on severe adverse event with…Dec 22, 2025 Industry Trial Results for Investigational Glanzmann Thrombasthenia…Dec 12, 2025 Advocacy & Legislative HELP Copays Act Reintroduced to Improve Patient AccessDec 11, 2025 Industry Five Year Hemgenix® Hemophilia B Trial Data Published in NEJMDec 10, 2025 Advocacy & Legislative Government Relations Update – November 2025Dec 10, 2025 Industry Interim Data for Investigational Sub-Q VWD Therapy Presented at ASHDec 9, 2025 NBDF & Community Facts About Inhibitors Now Available in Arabic!Dec 5, 2025 NBDF & Community NBDF Highlights Resources for Caregivers of People with Bleeding Disorders…Dec 4, 2025 NBDF & Community NBDF’s 2025 Research Roundtable: Advancing Bleeding…Nov 21, 2025 Medical Women and Girls with Hemophilia Booklet Now Available in ArabicNov 17, 2025 NBDF & Community Spotlight on SeraGene, a Pathway to Cure’s Portfolio CompanyNov 13, 2025 Medical MASAC Approves Recommendations on Non-Factor Hemophilia…Nov 12, 2025 Advocacy & Legislative Government Relations Update - October 2025Nov 12, 2025 Peer-Reviewed Journal Summaries WFH Publishes First Ever Guidelines for Hemophilia AAV Gene TherapyNov 6, 2025 Industry BioMarin Announces ROCTAVIAN Out-Licensing Plans for Hemophilia A Therapy…Oct 31, 2025 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page